CLINICAL_TRIALS
trial_result
· 2023-05-06
Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia [Phase 3]
Summary
A Phase 3 trial evaluating ceftobiprole for Staphylococcus aureus bacteremia has completed, with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Basilea Pharmaceutica | Conditions: Staphylococcus Aureus Bacteremia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-06